APO Research
Talk to an analyst

APO RESEARCH · REPORT

Clinical Trial Laboratory Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Clinical Trial Laboratory Testing Market Analysis and Forecast 2026-2032

3 May 2026241 pages

Choose your research edition.

Industry ResearchClinical Trial Laboratory Testing Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Clinical Trial Laboratory Testing Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Clinical Trial Laboratory Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clinical Trial Laboratory Testing Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Clinical Trial Laboratory Testing Market Analysis and Forecast 2026-2032241 pages · $4,950 USD

Market perspective

The global Clinical Trial Laboratory Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Clinical Trial Laboratory Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Clinical Trial Laboratory Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Clinical Trial Laboratory Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Clinical Trial Laboratory Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Clinical Trial Laboratory Testing include SGS, LabCorp, Cerba Research, IQVIA Q² Solutions, Eurofins, Charles River, ACM Global Laboratories, Australian Clinical Labs and PPD, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Clinical Trial Laboratory Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Clinical Trial Laboratory Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Clinical Trial Laboratory Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Clinical Trial Laboratory Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Clinical Trial Laboratory Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Clinical Trial Laboratory Testing revenue, projected growth trends, production technology, application and end-user industry.

Clinical Trial Laboratory Testing Segment by Company

SGS

LabCorp

Cerba Research

IQVIA Q² Solutions

Eurofins

Charles River

ACM Global Laboratories

Australian Clinical Labs

PPD

Almac Group

Mayo Clinic

LabConnect

Pharmaron

Frontage

WuXi AppTec

CTI

KingMed

CIRS

Clinical Trial Laboratory Testing Segment by Type

Central Laboratory Services

Clinical Bioanalysis Services

Genomics and Biomarkers

Other Services

Clinical Trial Laboratory Testing Segment by Application

Pharmaceuticals

Biotechnology

Medical Devices

Other

Clinical Trial Laboratory Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Laboratory Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Laboratory Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Laboratory Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Clinical Trial Laboratory Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Clinical Trial Laboratory Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Laboratory Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Clinical Trial Laboratory Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Central Laboratory Services Major Player Table 3. Clinical Bioanalysis Services Major Player Table 4. Genomics and Biomarkers Major Player Table 5. Other Services Major Player Table 6. Global Clinical Trial Laboratory Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceuticals Major Player Table 8. Biotechnology Major Player Table 9. Medical Devices Major Player Table 10. Other Major Player Table 11. Clinical Trial Laboratory Testing Industry Trends Table 12. Clinical Trial Laboratory Testing Industry Drivers Table 13. Clinical Trial Laboratory Testing Industry Opportunities and Challenges Table 14. Clinical Trial Laboratory Testing Industry Restraints Table 15. Global Clinical Trial Laboratory Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Clinical Trial Laboratory Testing Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Clinical Trial Laboratory Testing Market Share by Region (2021-2026) Table 18. Global Clinical Trial Laboratory Testing Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Clinical Trial Laboratory Testing Market Share by Region (2027-2032) Table 20. Global Clinical Trial Laboratory Testing Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Clinical Trial Laboratory Testing Revenue Market Share by Players (2021-2026) Table 22. Global Clinical Trial Laboratory Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Clinical Trial Laboratory Testing Key Players Headquarters & Area Served Table 24. Global Clinical Trial Laboratory Testing Players, Product Type & Application Table 25. Global Clinical Trial Laboratory Testing Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Clinical Trial Laboratory Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Clinical Trial Laboratory Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Clinical Trial Laboratory Testing Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Clinical Trial Laboratory Testing Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Clinical Trial Laboratory Testing Revenue Market Share by Type (2021-2026) Table 32. Global Clinical Trial Laboratory Testing Revenue Market Share by Type (2027-2032) Table 33. Global Clinical Trial Laboratory Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Clinical Trial Laboratory Testing Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Clinical Trial Laboratory Testing Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Clinical Trial Laboratory Testing Revenue Market Share by Application (2021-2026) Table 37. Global Clinical Trial Laboratory Testing Revenue Market Share by Application (2027-2032) Table 38. SGS Company Information Table 39. SGS Business Overview Table 40. SGS Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. SGS Clinical Trial Laboratory Testing Product Portfolio Table 42. SGS Recent Development Table 43. LabCorp Company Information Table 44. LabCorp Business Overview Table 45. LabCorp Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. LabCorp Clinical Trial Laboratory Testing Product Portfolio Table 47. LabCorp Recent Development Table 48. Cerba Research Company Information Table 49. Cerba Research Business Overview Table 50. Cerba Research Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Cerba Research Clinical Trial Laboratory Testing Product Portfolio Table 52. Cerba Research Recent Development Table 53. IQVIA Q² Solutions Company Information Table 54. IQVIA Q² Solutions Business Overview Table 55. IQVIA Q² Solutions Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. IQVIA Q² Solutions Clinical Trial Laboratory Testing Product Portfolio Table 57. IQVIA Q² Solutions Recent Development Table 58. Eurofins Company Information Table 59. Eurofins Business Overview Table 60. Eurofins Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Eurofins Clinical Trial Laboratory Testing Product Portfolio Table 62. Eurofins Recent Development Table 63. Charles River Company Information Table 64. Charles River Business Overview Table 65. Charles River Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Charles River Clinical Trial Laboratory Testing Product Portfolio Table 67. Charles River Recent Development Table 68. ACM Global Laboratories Company Information Table 69. ACM Global Laboratories Business Overview Table 70. ACM Global Laboratories Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. ACM Global Laboratories Clinical Trial Laboratory Testing Product Portfolio Table 72. ACM Global Laboratories Recent Development Table 73. Australian Clinical Labs Company Information Table 74. Australian Clinical Labs Business Overview Table 75. Australian Clinical Labs Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Australian Clinical Labs Clinical Trial Laboratory Testing Product Portfolio Table 77. Australian Clinical Labs Recent Development Table 78. PPD Company Information Table 79. PPD Business Overview Table 80. PPD Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. PPD Clinical Trial Laboratory Testing Product Portfolio Table 82. PPD Recent Development Table 83. Almac Group Company Information Table 84. Almac Group Business Overview Table 85. Almac Group Clinical Trial Laboratory Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Almac Group Clinical Trial Laboratory Testing Product Portfolio Table 87. Almac Group Recent Development Table 88. Mayo Clinic Company Information Table 89. Mayo Clinic Business Overview Table 90. Mayo Clinic Clinical Trial Laboratory Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Mayo Clinic Clinical Trial Laboratory Testing Product Portfolio Table 92. Mayo Clinic Recent Development Table 93. LabConnect Company Information Table 94. LabConnect Business Overview Table 95. LabConnect Clinical Trial Laboratory Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. LabConnect Clinical Trial Laboratory Testing Product Portfolio Table 97. LabConnect Recent Development Table 98. Pharmaron Company Information Table 99. Pharmaron Business Overview Table 100. Pharmaron Clinical Trial Laboratory Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Pharmaron Clinical Trial Laboratory Testing Product Portfolio Table 102. Pharmaron Recent Development Table 103. Frontage Company Information Table 104. Frontage Business Overview Table 105. Frontage Clinical Trial Laboratory Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Frontage Clinical Trial Laboratory Testing Product Portfolio Table 107. Frontage Recent Development Table 108. WuXi AppTec Company Information Table 109. WuXi AppTec Business Overview Table 110. WuXi AppTec Clinical Trial Laboratory Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. WuXi AppTec Clinical Trial Laboratory Testing Product Portfolio Table 112. WuXi AppTec Recent Development Table 113. CTI Company Information Table 114. CTI Business Overview Table 115. CTI Clinical Trial Laboratory Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. CTI Clinical Trial Laboratory Testing Product Portfolio Table 117. CTI Recent Development Table 118. KingMed Company Information Table 119. KingMed Business Overview Table 120. KingMed Clinical Trial Laboratory Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. KingMed Clinical Trial Laboratory Testing Product Portfolio Table 122. KingMed Recent Development Table 123. CIRS Company Information Table 124. CIRS Business Overview Table 125. CIRS Clinical Trial Laboratory Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. CIRS Clinical Trial Laboratory Testing Product Portfolio Table 127. CIRS Recent Development Table 128. North America Clinical Trial Laboratory Testing Revenue by Type (2021-2026) & (US$ Million) Table 129. North America Clinical Trial Laboratory Testing Revenue by Type (2027-2032) & (US$ Million) Table 130. North America Clinical Trial Laboratory Testing Revenue by Application (2021-2026) & (US$ Million) Table 131. North America Clinical Trial Laboratory Testing Revenue by Application (2027-2032) & (US$ Million) Table 132. North America Clinical Trial Laboratory Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. North America Clinical Trial Laboratory Testing Revenue by Country (2021-2026) & (US$ Million) Table 134. North America Clinical Trial Laboratory Testing Revenue by Country (US$ Million) & (2027-2032) Table 135. Europe Clinical Trial Laboratory Testing Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Clinical Trial Laboratory Testing Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Clinical Trial Laboratory Testing Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Clinical Trial Laboratory Testing Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Clinical Trial Laboratory Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Clinical Trial Laboratory Testing Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Clinical Trial Laboratory Testing Revenue by Country (US$ Million) & (2027-2032) Table 142. China Clinical Trial Laboratory Testing Revenue by Type (2021-2026) & (US$ Million) Table 143. China Clinical Trial Laboratory Testing Revenue by Type (2027-2032) & (US$ Million) Table 144. China Clinical Trial Laboratory Testing Revenue by Application (2021-2026) & (US$ Million) Table 145. China Clinical Trial Laboratory Testing Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Clinical Trial Laboratory Testing Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Clinical Trial Laboratory Testing Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Clinical Trial Laboratory Testing Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Clinical Trial Laboratory Testing Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Clinical Trial Laboratory Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Asia Clinical Trial Laboratory Testing Revenue by Region (US$ Million) & (2021-2026) Table 152. Asia Clinical Trial Laboratory Testing Revenue by Region (US$ Million) & (2027-2032) Table 153. SAMEA Clinical Trial Laboratory Testing Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Clinical Trial Laboratory Testing Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Clinical Trial Laboratory Testing Revenue by Application (2021-2026) & (US$ Million) Table 156. SAMEA Clinical Trial Laboratory Testing Revenue by Application (2027-2032) & (US$ Million) Table 157. SAMEA Clinical Trial Laboratory Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. SAMEA Clinical Trial Laboratory Testing Revenue by Country (2021-2026) & (US$ Million) Table 159. SAMEA Clinical Trial Laboratory Testing Revenue by Country (US$ Million) & (2027-2032) Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Clinical Trial Laboratory Testing Image Figure 2. Global Clinical Trial Laboratory Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clinical Trial Laboratory Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Central Laboratory Services Image Figure 5. Clinical Bioanalysis Services Image Figure 6. Genomics and Biomarkers Image Figure 7. Other Services Image Figure 8. Global Clinical Trial Laboratory Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Clinical Trial Laboratory Testing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceuticals Image Figure 11. Biotechnology Image Figure 12. Medical Devices Image Figure 13. Other Image Figure 14. Global Clinical Trial Laboratory Testing Market Size (US$ Million) & (2021-2032) Figure 15. Global Clinical Trial Laboratory Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Clinical Trial Laboratory Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Clinical Trial Laboratory Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Clinical Trial Laboratory Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Clinical Trial Laboratory Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Clinical Trial Laboratory Testing Revenue Market Share by Type (2021-2032) Figure 22. Global Clinical Trial Laboratory Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Clinical Trial Laboratory Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Clinical Trial Laboratory Testing Revenue Market Share by Application (2021-2032) Figure 25. North America Clinical Trial Laboratory Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032) Figure 27. North America Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032) Figure 28. North America Clinical Trial Laboratory Testing Revenue Share by Country (2021-2032) Figure 29. United States Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Clinical Trial Laboratory Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032) Figure 34. Europe Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032) Figure 35. Europe Clinical Trial Laboratory Testing Revenue Share by Country (2021-2032) Figure 36. Germany Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Clinical Trial Laboratory Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032) Figure 46. China Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032) Figure 47. Asia Clinical Trial Laboratory Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032) Figure 49. Asia Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032) Figure 50. Asia Clinical Trial Laboratory Testing Revenue Share by Region (2021-2032) Figure 51. Japan Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Clinical Trial Laboratory Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032) Figure 59. SAMEA Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032) Figure 60. SAMEA Clinical Trial Laboratory Testing Revenue Share by Country (2021-2032) Figure 61. Brazil Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Clinical Trial Laboratory Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Central Laboratory Services
  • Clinical Bioanalysis Services
  • Genomics and Biomarkers
  • Other Services
Applications
  • Pharmaceuticals
  • Biotechnology
  • Medical Devices
  • Other
Companies covered
  • SGS
  • LabCorp
  • Cerba Research
  • IQVIA Q² Solutions
  • Eurofins
  • Charles River
  • ACM Global Laboratories
  • Australian Clinical Labs
  • PPD
  • Almac Group
  • Mayo Clinic
  • LabConnect
  • Pharmaron
  • Frontage
  • WuXi AppTec
  • CTI
  • KingMed
  • CIRS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Clinical Trial Laboratory Testing Market by Type
  3. 1.2.1 Global Clinical Trial Laboratory Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Central Laboratory Services
  5. 1.2.3 Clinical Bioanalysis Services
  6. 1.2.4 Genomics and Biomarkers
  7. 1.2.5 Other Services
  8. 1.3 Clinical Trial Laboratory Testing Market by Application
  9. 1.3.1 Global Clinical Trial Laboratory Testing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceuticals
  11. 1.3.3 Biotechnology
  12. 1.3.4 Medical Devices
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Clinical Trial Laboratory Testing Market Dynamics
  1. 2.1 Clinical Trial Laboratory Testing Industry Trends
  2. 2.2 Clinical Trial Laboratory Testing Industry Drivers
  3. 2.3 Clinical Trial Laboratory Testing Industry Opportunities and Challenges
  4. 2.4 Clinical Trial Laboratory Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Clinical Trial Laboratory Testing Market Perspective (2021-2032)
  2. 3.2 Global Clinical Trial Laboratory Testing Growth Trends by Region
  3. 3.2.1 Global Clinical Trial Laboratory Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Clinical Trial Laboratory Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Clinical Trial Laboratory Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Clinical Trial Laboratory Testing Revenue by Players
  2. 4.1.1 Global Clinical Trial Laboratory Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Clinical Trial Laboratory Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Clinical Trial Laboratory Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Clinical Trial Laboratory Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Clinical Trial Laboratory Testing Key Players Headquarters & Area Served
  7. 4.4 Global Clinical Trial Laboratory Testing Players, Product Type & Application
  8. 4.5 Global Clinical Trial Laboratory Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Clinical Trial Laboratory Testing Market CR5 and HHI
  11. 4.6.3 2025 Clinical Trial Laboratory Testing Tier 1, Tier 2, and Tier 3
5 Clinical Trial Laboratory Testing Market Size by Type
  1. 5.1 Global Clinical Trial Laboratory Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Clinical Trial Laboratory Testing Revenue by Type (2021-2032)
  3. 5.3 Global Clinical Trial Laboratory Testing Revenue Market Share by Type (2021-2032)
6 Clinical Trial Laboratory Testing Market Size by Application
  1. 6.1 Global Clinical Trial Laboratory Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Clinical Trial Laboratory Testing Revenue by Application (2021-2032)
  3. 6.3 Global Clinical Trial Laboratory Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SGS
  2. 7.1.1 SGS Company Information
  3. 7.1.2 SGS Business Overview
  4. 7.1.3 SGS Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SGS Clinical Trial Laboratory Testing Product Portfolio
  6. 7.1.5 SGS Recent Developments
  7. 7.2 LabCorp
  8. 7.2.1 LabCorp Company Information
  9. 7.2.2 LabCorp Business Overview
  10. 7.2.3 LabCorp Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 LabCorp Clinical Trial Laboratory Testing Product Portfolio
  12. 7.2.5 LabCorp Recent Developments
  13. 7.3 Cerba Research
  14. 7.3.1 Cerba Research Company Information
  15. 7.3.2 Cerba Research Business Overview
  16. 7.3.3 Cerba Research Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cerba Research Clinical Trial Laboratory Testing Product Portfolio
  18. 7.3.5 Cerba Research Recent Developments
  19. 7.4 IQVIA Q² Solutions
  20. 7.4.1 IQVIA Q² Solutions Company Information
  21. 7.4.2 IQVIA Q² Solutions Business Overview
  22. 7.4.3 IQVIA Q² Solutions Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 IQVIA Q² Solutions Clinical Trial Laboratory Testing Product Portfolio
  24. 7.4.5 IQVIA Q² Solutions Recent Developments
  25. 7.5 Eurofins
  26. 7.5.1 Eurofins Company Information
  27. 7.5.2 Eurofins Business Overview
  28. 7.5.3 Eurofins Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins Clinical Trial Laboratory Testing Product Portfolio
  30. 7.5.5 Eurofins Recent Developments
  31. 7.6 Charles River
  32. 7.6.1 Charles River Company Information
  33. 7.6.2 Charles River Business Overview
  34. 7.6.3 Charles River Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Charles River Clinical Trial Laboratory Testing Product Portfolio
  36. 7.6.5 Charles River Recent Developments
  37. 7.7 ACM Global Laboratories
  38. 7.7.1 ACM Global Laboratories Company Information
  39. 7.7.2 ACM Global Laboratories Business Overview
  40. 7.7.3 ACM Global Laboratories Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ACM Global Laboratories Clinical Trial Laboratory Testing Product Portfolio
  42. 7.7.5 ACM Global Laboratories Recent Developments
  43. 7.8 Australian Clinical Labs
  44. 7.8.1 Australian Clinical Labs Company Information
  45. 7.8.2 Australian Clinical Labs Business Overview
  46. 7.8.3 Australian Clinical Labs Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Australian Clinical Labs Clinical Trial Laboratory Testing Product Portfolio
  48. 7.8.5 Australian Clinical Labs Recent Developments
  49. 7.9 PPD
  50. 7.9.1 PPD Company Information
  51. 7.9.2 PPD Business Overview
  52. 7.9.3 PPD Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 PPD Clinical Trial Laboratory Testing Product Portfolio
  54. 7.9.5 PPD Recent Developments
  55. 7.10 Almac Group
  56. 7.10.1 Almac Group Company Information
  57. 7.10.2 Almac Group Business Overview
  58. 7.10.3 Almac Group Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Almac Group Clinical Trial Laboratory Testing Product Portfolio
  60. 7.10.5 Almac Group Recent Developments
  61. 7.11 Mayo Clinic
  62. 7.11.1 Mayo Clinic Company Information
  63. 7.11.2 Mayo Clinic Business Overview
  64. 7.11.3 Mayo Clinic Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Mayo Clinic Clinical Trial Laboratory Testing Product Portfolio
  66. 7.11.5 Mayo Clinic Recent Developments
  67. 7.12 LabConnect
  68. 7.12.1 LabConnect Company Information
  69. 7.12.2 LabConnect Business Overview
  70. 7.12.3 LabConnect Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 LabConnect Clinical Trial Laboratory Testing Product Portfolio
  72. 7.12.5 LabConnect Recent Developments
  73. 7.13 Pharmaron
  74. 7.13.1 Pharmaron Company Information
  75. 7.13.2 Pharmaron Business Overview
  76. 7.13.3 Pharmaron Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Pharmaron Clinical Trial Laboratory Testing Product Portfolio
  78. 7.13.5 Pharmaron Recent Developments
  79. 7.14 Frontage
  80. 7.14.1 Frontage Company Information
  81. 7.14.2 Frontage Business Overview
  82. 7.14.3 Frontage Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Frontage Clinical Trial Laboratory Testing Product Portfolio
  84. 7.14.5 Frontage Recent Developments
  85. 7.15 WuXi AppTec
  86. 7.15.1 WuXi AppTec Company Information
  87. 7.15.2 WuXi AppTec Business Overview
  88. 7.15.3 WuXi AppTec Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 WuXi AppTec Clinical Trial Laboratory Testing Product Portfolio
  90. 7.15.5 WuXi AppTec Recent Developments
  91. 7.16 CTI
  92. 7.16.1 CTI Company Information
  93. 7.16.2 CTI Business Overview
  94. 7.16.3 CTI Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 CTI Clinical Trial Laboratory Testing Product Portfolio
  96. 7.16.5 CTI Recent Developments
  97. 7.17 KingMed
  98. 7.17.1 KingMed Company Information
  99. 7.17.2 KingMed Business Overview
  100. 7.17.3 KingMed Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 KingMed Clinical Trial Laboratory Testing Product Portfolio
  102. 7.17.5 KingMed Recent Developments
  103. 7.18 CIRS
  104. 7.18.1 CIRS Company Information
  105. 7.18.2 CIRS Business Overview
  106. 7.18.3 CIRS Clinical Trial Laboratory Testing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 CIRS Clinical Trial Laboratory Testing Product Portfolio
  108. 7.18.5 CIRS Recent Developments
8 North America
  1. 8.1 North America Clinical Trial Laboratory Testing Revenue (2021-2032)
  2. 8.2 North America Clinical Trial Laboratory Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Clinical Trial Laboratory Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Clinical Trial Laboratory Testing Revenue by Type (2027-2032)
  5. 8.3 North America Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Clinical Trial Laboratory Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Clinical Trial Laboratory Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Clinical Trial Laboratory Testing Revenue by Application (2027-2032)
  9. 8.5 North America Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Clinical Trial Laboratory Testing Revenue by Country
  11. 8.6.1 North America Clinical Trial Laboratory Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Clinical Trial Laboratory Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Clinical Trial Laboratory Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Clinical Trial Laboratory Testing Revenue (2021-2032)
  2. 9.2 Europe Clinical Trial Laboratory Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Clinical Trial Laboratory Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Clinical Trial Laboratory Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Clinical Trial Laboratory Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Clinical Trial Laboratory Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Clinical Trial Laboratory Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Clinical Trial Laboratory Testing Revenue by Country
  11. 9.6.1 Europe Clinical Trial Laboratory Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Clinical Trial Laboratory Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Clinical Trial Laboratory Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Clinical Trial Laboratory Testing Revenue (2021-2032)
  2. 10.2 China Clinical Trial Laboratory Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Clinical Trial Laboratory Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Clinical Trial Laboratory Testing Revenue by Type (2027-2032)
  5. 10.3 China Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Clinical Trial Laboratory Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Clinical Trial Laboratory Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Clinical Trial Laboratory Testing Revenue by Application (2027-2032)
  9. 10.5 China Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Clinical Trial Laboratory Testing Revenue (2021-2032)
  2. 11.2 Asia Clinical Trial Laboratory Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Clinical Trial Laboratory Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Clinical Trial Laboratory Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Clinical Trial Laboratory Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Clinical Trial Laboratory Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Clinical Trial Laboratory Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Clinical Trial Laboratory Testing Revenue by Country
  11. 11.6.1 Asia Clinical Trial Laboratory Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Clinical Trial Laboratory Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Clinical Trial Laboratory Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Clinical Trial Laboratory Testing Revenue (2021-2032)
  2. 12.2 SAMEA Clinical Trial Laboratory Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Clinical Trial Laboratory Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Clinical Trial Laboratory Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Clinical Trial Laboratory Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Clinical Trial Laboratory Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Clinical Trial Laboratory Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Clinical Trial Laboratory Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Clinical Trial Laboratory Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Clinical Trial Laboratory Testing Revenue by Country
  11. 12.6.1 SAMEA Clinical Trial Laboratory Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Clinical Trial Laboratory Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Clinical Trial Laboratory Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst